Meng-chih F. Lin-Chien

Kaohsiung, KHQ 80173, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 192 publications

Whole-transcriptome sequencing analysis to identify key non-coding RNAs in the pathogenesis of pulmonary tuberculosis.

Whole-transcriptome sequencing analysis to identify key non-coding RNAs in the pathogenesis of pulmonary tuberculosis.

Journal: Public health action
Published: April 18, 2026

Increased HLA-DR Expression on M2a Monocytes and Helper T Cells in Patients with COPD and Asthma-COPD Overlap Contributes to Disease Severity via Apoptosis and ROS.

Increased HLA-DR Expression on M2a Monocytes and Helper T Cells in Patients with COPD and Asthma-COPD Overlap Contributes to Disease Severity via Apoptosis and ROS.

Journal: Antioxidants (Basel, Switzerland)
Published: November 03, 2025

Pathophysiological impacts of particulate matter exposure on respiratory health and emerging biomarkers for early detection.

Pathophysiological impacts of particulate matter exposure on respiratory health and emerging biomarkers for early detection.

Journal: Journal of pharmaceutical and biomedical analysis
Published: September 11, 2025

Stress Hormone Dysregulation in Overweight Male Adults with Obstructive Sleep Apnea.

Stress Hormone Dysregulation in Overweight Male Adults with Obstructive Sleep Apnea.

Journal: Neuroendocrinology
Published: June 26, 2025

Increased autophagy activity regulated by LC3B gene promoter DNA methylation is associated with progression to active pulmonary tuberculosis disease.

Increased autophagy activity regulated by LC3B gene promoter DNA methylation is associated with progression to active pulmonary tuberculosis disease.

Journal: Respiratory research
Published: November 07, 2024

Chronic obstructive pulmonary disease mortality rate trends in Taiwan, 2002-2022: a joinpoint regression analysis.

Chronic obstructive pulmonary disease mortality rate trends in Taiwan, 2002-2022: a joinpoint regression analysis.

Journal: BMJ open respiratory research
Published: October 04, 2024

Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study.

Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study.

Journal: Biomedicines
Published: August 16, 2024

Exploring Occupational Asthmagen-Related Asthma Phenotypes: A Cluster Analysis and Machine Learning Study.

Exploring Occupational Asthmagen-Related Asthma Phenotypes: A Cluster Analysis and Machine Learning Study.

Journal: Allergy
Published: August 07, 2024

Enhancing Outcomes in Chronic Fibrotic Interstitial Lung Disease Through Aggressive Management of Nintedanib-Induced Adverse Drug Reactions: A Retrospective Analysis.

Enhancing Outcomes in Chronic Fibrotic Interstitial Lung Disease Through Aggressive Management of Nintedanib-Induced Adverse Drug Reactions: A Retrospective Analysis.

Journal: Drugs - real world outcomes
Published: June 16, 2024

Sex Differences in the Expression of Cardiac Remodeling and Inflammatory Cytokines in Patients with Obstructive Sleep Apnea and Atrial Fibrillation.

Sex Differences in the Expression of Cardiac Remodeling and Inflammatory Cytokines in Patients with Obstructive Sleep Apnea and Atrial Fibrillation.

Journal: Biomedicines
Published: April 28, 2024

The long-term outcome of chronic thromboembolic pulmonary hypertension: Pulmonary endarterectomy and balloon pulmonary angioplasty.

The long-term outcome of chronic thromboembolic pulmonary hypertension: Pulmonary endarterectomy and balloon pulmonary angioplasty.

Journal: Journal of the Chinese Medical Association : JCMA
Published: January 22, 2024

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722.

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 22, 2024
Showing 1-12 of 192

Last Updated: 09/26/2026